Related Experiment Video
Updated: Oct 2, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
[Why does nitroglycerin tolerance appear?]
1Instytut Biochemii Lekarskiej Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Abstract:
Nitroglycerin (NTG) and other organic nitrates are beneficial drugs for the treatment of acute forms of coronary artery disease. The major limitation of organic nitrates use in clinical practice is the rapid development of hemodynamic tolerance. In general mechanisms of tolerance can be categorized into two different groups. One group of mechanisms is related to changes in the vascular smooth muscle bioactivation of organic nitrates. The other mechanisms are related to physiological response to increase nitric oxide (NO) production.
Insights
Organic nitrates like nitroglycerin effectively treat coronary artery disease but cause tolerance. This tolerance stems from altered vascular smooth muscle bioactivation or physiological responses to increased nitric oxide production.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Biochemistry
Context:
- Organic nitrates, including nitroglycerin, are vital for managing acute coronary artery disease.
- Hemodynamic tolerance significantly limits the long-term efficacy of these essential medications.
- Understanding tolerance mechanisms is crucial for optimizing nitrate therapy.
Purpose:
- To review and categorize the primary mechanisms underlying the development of hemodynamic tolerance to organic nitrates.
- To differentiate between vascular bioactivation changes and physiological responses to nitric oxide.
Summary:
- Tolerance to organic nitrates involves two main categories of mechanisms.
- These include alterations in how vascular smooth muscle bioactivates nitrates.
- They also encompass physiological adaptations in response to increased nitric oxide (NO) signaling.
Impact:
- Provides a framework for understanding nitrate tolerance in clinical practice.
- Highlights key pathways that may be targeted for future therapeutic interventions.
- Aids researchers in focusing on specific mechanisms to overcome drug limitations.
More Related Videos
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Drug Delivery: Enteral Route
Drugs in...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Desensitization and Tachyphylaxis
Several...

